Elanco Animal Health: Peers

The FY2025 (Dec) proxy of Elanco Animal Health names 18 peer companies for pay. Among Elanco Animal Health and these peers, CEO pay was 6th highest of 11 and total shareholder return was 7th highest of 11.

6th highest of 11in Elanco Animal Health and its pay peers, FY2025 (Dec) by CEO pay:

$8.8M$32.1M

7th highest of 11in Elanco Animal Health and its pay peers, FY2025 (Dec) by total shareholder return:

$24$148

Pay peer group, FY2025 (Dec) proxy

Incyte
Zoetis
Edwards Lifesciences
Zimmer Biomet Holdings
Charles River Laboratories International
Revvity
Agilent Technologies
STERIS
PERRIGO Co
Dentsply Sirona
Bausch Health Companies Inc.Not disclosedNot disclosed
BiogenNot disclosedNot disclosed
Catalent, Inc.Not disclosedNot disclosed
Hologic, Inc.Not disclosedNot disclosed
IDEXX Laboratories, Inc.Not disclosedNot disclosed
Jazz PharmaceuticalsNot disclosedNot disclosed
QuidelOrtho CorporationNot disclosedNot disclosed
Vertex Pharmaceuticals, Inc.Not disclosedNot disclosed
18 companies

Changes by year

FY2025 (Dec) proxy

  • AddedBausch Health Companies Inc.pay peer groupThe Committee added Bausch Health Companies Inc. and Biogen Inc. to increase the representation of biotech and pharmaceutical companies in Elanco’s peer group, as the Committee feels that these industries are comparable to Elanco and require similar talent
  • AddedBiogenpay peer groupThe Committee added Bausch Health Companies Inc. and Biogen Inc. to increase the representation of biotech and pharmaceutical companies in Elanco’s peer group, as the Committee feels that these industries are comparable to Elanco and require similar talent
  • RemovedHorizon Therapeuticspay peer groupbecause it was acquired in 2023 and thus did not release a proxy statement for that fiscal year

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.